← Back to headlines
Eli Lilly and InSilico Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly has struck a deal with InSilico for AI-powered drug discovery, as reported by the Wall Street Journal.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
